BioSmart Brief: Highlights NeoStem's PreSERVE Trial

BioSmart Brief: Highlights NeoStem's PreSERVE Trial

PreSERVE-AMI tests autologous stem cell treatment for heart attack
Doctors at Orlando Health have started a trial as part of the nationwide PreSERVE-AMI study of pelvic bone marrow stem cells in treating tissue damage after a heart attack. The study of autologous transplant will involve 160 patients at 34 sites. American City Business Journals/Orlando, Fla.